Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

OPKO Health Inc OPK

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.


NDAQ:OPK - Post by User

Post by whytestockson Aug 04, 2023 1:15am
129 Views
Post# 35572584

Opko Health (OPK) Q2 2023 Earnings Call Transcript

Opko Health (OPK) Q2 2023 Earnings Call Transcript
BREAKING NEWS: $OPK Opko Health (OPK) Q2 2023 Earnings Call Transcript2023-08-04 01:00:22 ET Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q2 2023 Earnings Call Aug 03, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q2 2023 Earnings Call TranscriptOPK - Opko Health (OPK) Q2 2023 Earnings Call Transcript

<< Previous
Bullboard Posts
Next >>